BAISONG ZHAO, Ph.D in pharmacology, Researcher, Professor, Doctoral Supervisor. Director of Hengpu Life Science Research Center at Southern University of Science & Technology. Director of Shenzhen Overseas Chinese scientists Expert Committee. Vice President of Shenzhen Pharmaceutical Industry Association. Visiting Professor of Peking University, Expert of Joint Laboratory of medical intelligent testing and data certification. Visiting professor and young and middle-aged expert with outstanding contributions. Chief expert and senior researcher of the Chinese Academy of Management Sciences and a member of the national pharmaceutical think tank. President of the Institute of aging health and anti-aging, China geriatric health care Medical Research Association, and director of the office of China aging health promotion project - elderly health and anti-aging practice base. Director of precision medical Promotion Project Office of China Life Care Association, director of anti-aging Project Research Office of China Life Care Association, and director of anti-tumor research office of China Life Care Association. China's returned overseas business experts Steering Committee entrepreneurial mentor. Head of the preparatory group of the biomedical special committee of the European and American Students Association. Director of international technology transfer center for bio-medicine between China and US. Member of the expert group of the Ministry of science and technology, Ministry of human resources and social security, and Health Commission. Excellent talents from the Ministry of human resources and social security. The first batch of special experts in the "Hundred Talents Program". High level talents of innovation and entrepreneurship in Zhuhai. The first batch of "Changbai Huigu" talents plan overseas high-end leading talents. Dr. Baisong Zhao has more than 20 years of working experience in multinational companies. He has served as a middle and senior manager in the University Medical School and internationally renowned biomedical enterprises such as Pfizer, Procter & Gamble, Genzyme and Sanofi, presided over the innovation research and clinical trials of more than 13 new products, participated in R & D of more than 7 new products, obtained more than 13 invention patents, and made reports at more than 30 international conferences.